HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
ESPR
Esperion Therapeutics Inc
Healthcare Drug Manufacturers - Specialty & Generic · Michigan, USA · Reports in usd
Market Cap: $809.0M
Market Cap
$809.0M
Enterprise Val
$1.20B
P/E Ratio
-108.98
P/B Ratio
-2.63
Trailing PEG (1Y)
2.08
As Of
Jun 23, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value-$307.9M
Gross Margin56.84%
Profit Margin56.84%
Return on Equity1.99%
Return on Assets-1.81%
Current Ratio1.53
Debt/Equity-1.77
LT Debt/Equity-1.50
Revenue Per Share0.31

Income Statement

Mar 31, 2026
Revenue$80.1M
Cost of Revenue$34.6M
Gross Profit$45.5M
R&D$9.0M
SG&A$43.1M
Operating Expenses$52.1M
Operating Income-$6.6M
Interest Expense$19.8M
Tax Expense$0.00
Net Income-$25.2M
EPS (Basic)$-0.10
EPS (Diluted)$-0.10
EBIT-$5.4M
EBITDA-$5.4M
Consolidated Income-$25.2M
Non-Controlling Interests$0.00

Balance Sheet

Mar 31, 2026
Cash & Equivalents$156.2M
Accounts Receivable$132.4M
Inventory$104.2M
Current Assets$459.5M
LT Investments$0.00
Property, Plant & Equipment$3.0M
Intangibles$56.0K
Non-Current Assets$3.1M
Total Assets$462.5M
Accounts Payable$68.4M
Current Debt$82.4M
Current Liabilities$300.4M
LT Debt$461.4M
Non-Current Liabilities$470.1M
Total Liabilities$770.5M
Total Debt$543.8M
Retained Earnings-$1.65B
Shareholder Equity-$307.9M
Shares Outstanding256,810,482

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow-$27.7M
Investing Cash Flow-$189.0K
Financing Cash Flow$16.2M
CapEx-$189.0K
Free Cash Flow-$27.9M
Depreciation & Amort.$27.0K
Stock-Based Comp$2.5M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid$0.00
Equity Issued/Repaid$16.2M
Dividends Paid$0.00
Net Change in Cash-$11.7M
Data cached · Meta live · Daily live · Statements live · TTL 24h